Search - tctmd.com

Displaying 241 - 260 of 318

Sort: Relevancy | Date

Presentation

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

February 06, 2019

Manuscript

Calcification and Thrombosis as Mediators of Bioprosthetic Valve Deterioration

February 06, 2019

News Conference News STS 2019

TAVR More Prevalent in Highly Competitive Hospital Markets

Yael L. Maxwell

February 04, 2019

News Conference News STS 2019

Past SAVR Outcomes Matter More Than Volume in Determining Future Performance

Yael L. Maxwell

January 31, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2019

Caitlin E. Cox

January 31, 2019

Presentation

Case Volume and Outcomes After TAVR With Balloon-Expandable Prostheses

January 30, 2019

News Daily News

Is There a Volume-Outcome Relationship With Newer TAVR Valves? Maybe Not, Registry Suggests

Todd Neale

January 30, 2019

News Conference News STS 2019

TAVR-Related Complications, High Resource Use Decreasing at a Surgeon-Led Program

Yael L. Maxwell

January 30, 2019

Presentation STS 2019

J. Maxwell Chamberlain Memorial Paper: Relationship Between Hospital Surgical Aortic Valve Replacement Volume and Transcatheter Aortic Valve Replacement Outcomes

Presenter: Sameer Hirji

January 29, 2019

Presentation STS 2019

Aortic Valve Replacement in Bioprosthetic Failure: Insights from STS National Database

Presenter: Ankur Kalra

January 29, 2019

News Conference News STS 2019

TAVR Outcomes Dependent on SAVR Hospital Volumes

Yael L. Maxwell

January 28, 2019

News Daily News

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

L.A. McKeown

January 21, 2019

News Daily News

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

L.A. McKeown

January 17, 2019

News Daily News

New CT Guidelines for TAVR Emphasize Standardization, 4-D Acquisition, and Postprocedural Imaging

Yael L. Maxwell

January 14, 2019

News Daily News

FDA Approves Pea-Sized Occluder for Patent Ductus Arteriosus in Premature Babies

L.A. McKeown

January 14, 2019

News Daily News

Half of TAVR Patients Develop Potentially Dangerous Conduction Abnormalities

Yael L. Maxwell

January 11, 2019

Presentation

TAVR in Oncology Patients With Severe AS

January 10, 2019

News Daily News

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

L.A. McKeown

January 10, 2019

News Daily News

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

Todd Neale

January 09, 2019

Manuscript

Systematic Transfemoral Transarterial Transcatheter Aortic Valve Replacement in Hostile Vascular Access

January 07, 2019

Advertisement

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

Calcification and Thrombosis as Mediators of Bioprosthetic Valve Deterioration

TAVR More Prevalent in Highly Competitive Hospital Markets

Past SAVR Outcomes Matter More Than Volume in Determining Future Performance

TCTMD’s Top 10 Most Popular Stories for January 2019

Case Volume and Outcomes After TAVR With Balloon-Expandable Prostheses

Is There a Volume-Outcome Relationship With Newer TAVR Valves? Maybe Not, Registry Suggests

TAVR-Related Complications, High Resource Use Decreasing at a Surgeon-Led Program

J. Maxwell Chamberlain Memorial Paper: Relationship Between Hospital Surgical Aortic Valve Replacement Volume and Transcatheter Aortic Valve Replacement Outcomes

Aortic Valve Replacement in Bioprosthetic Failure: Insights from STS National Database

TAVR Outcomes Dependent on SAVR Hospital Volumes

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

New CT Guidelines for TAVR Emphasize Standardization, 4-D Acquisition, and Postprocedural Imaging

FDA Approves Pea-Sized Occluder for Patent Ductus Arteriosus in Premature Babies

Half of TAVR Patients Develop Potentially Dangerous Conduction Abnormalities

TAVR in Oncology Patients With Severe AS

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

Systematic Transfemoral Transarterial Transcatheter Aortic Valve Replacement in Hostile Vascular Access

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content